Live News Categoriesequity

Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) News

Follow Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 300683.SZ Asset equity Sector Markets 90 days 1 Last 24.77 Updated Oct 13, 2026, 11:15 AM UTC Open live news feed

L BRIEF — Wuhan Hiteck Biological Pharma Grants Visara Exclusive Rights To HT006.2.2 Outside Greater China Oct 13 (Reuters) — Wuhan Hiteck Biological Pharma Co Ltd: Wuhan Hiteck Biological Pharma Co - Grants Visara Exclusive Rights To Ht006.2.2 Outside Greater China Wuhan Hiteck Biological Pharma Co - To Receive Upfront Payme GEOPOLITICS | Oct 13, 2026, 11:15 AM UTC